Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$19.3M
-
Value change
-
+$2.73M
-
Number of buys
-
23
-
Number of sells
-
-10
-
Price
-
$1.14
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q1 2025
45 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 87.4M outstanding shares and own 19.33% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), TIFF ADVISORY SERVICES, LLC (2.98M shares), Balyasny Asset Management L.P. (2.15M shares), JOSH ARNOLD INVESTMENT CONSULTANT, LLC (1.99M shares), VANGUARD GROUP INC (1.75M shares), CINCINNATI INSURANCE CO (1.24M shares), FreeGulliver LLC (544K shares), GEODE CAPITAL MANAGEMENT, LLC (386K shares), Manatuck Hill Partners, LLC (350K shares), and BlackRock, Inc. (262K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.